Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2013
09/18/2013CN102351911B Method for synthesizing anticancer compound Na4Bi2Mn2W20C6H84N4O105
09/18/2013CN102337244B Dendritic cell loaded with antigen of tumor cell subjected to chemotherapy drug tolerance screening, its preparation method and application
09/18/2013CN102319217B Polysaccharide coated magnetic nano-particle and preparation method
09/18/2013CN102295640B 3-heterocycle schiff base-5-fluorine-indole-2-ketone compounds, preparation method thereof and application thereof
09/18/2013CN102271659B Liposome of irinotecan or its hydrochloride and preparation method thereof
09/18/2013CN102268455B CEA (chorioembryonic antigen) recombinant adeno-associated viral vector, constructing method thereof and application thereof
09/18/2013CN102260294B Binuclear platinum (II) complex or platinum (II) complex and application thereof
09/18/2013CN102250104B Camptothecin derivative, and its synthetic method and application
09/18/2013CN102204889B Degarelix acetate lyophilized powder injection and preparation method thereof
09/18/2013CN102174042B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions
09/18/2013CN102140470B Human miR-1236 antisense ribonucleic acid and application thereof
09/18/2013CN102060889B Stilbene glycoside derivative
09/18/2013CN102060848B Preparation and application of aromatic amine substituted pyrimidine derivatives
09/18/2013CN102046605B Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
09/18/2013CN102018672B Freeze-dried liposome composition of water-soluble medicament and preparation method thereof
09/18/2013CN101966332B Application of gap junction protein and coding gene thereof in preparing medicament for reversing malignant phenotype of cancer stem cell
09/18/2013CN101962642B Interference RNA for targeting CCP22 gene, medicament composition containing interference RNA and application thereof
09/18/2013CN101948540B Preparation of novel anti-EGFR human source antibody MIL27 and application thereof
09/18/2013CN101941077B Method for preparing magnetic metal iron-encapsulated fullerene carbon spheres
09/18/2013CN101856496B Placenta stem-cell anti-tumor vaccine, preparation method and application thereof
09/18/2013CN101744948B Extract from fruit shell of camellia oleifera abel and preparation method and application thereof
09/18/2013CN101712714B Semisynthetic trierpenoidsaponin with antitumor activity and medicinal composition thereof
09/18/2013CN101708158B Eriocalyxin B nanosuspension and preparation method thereof
09/18/2013CN101300272B Compositions and methods for treating proliferative disorders
09/18/2013CN101282994B Anti-CD26 antibodies and methods of use thereof
09/18/2013CN101282742B Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
09/18/2013CN101134102B 5T4 antigen-expressed vector
09/17/2013US8536348 Lactone formulations and method of use
09/17/2013US8536327 Epothilone derivatives
09/17/2013US8536311 Inhibitor protein of the wnt signal pathway
09/17/2013US8536188 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
09/17/2013US8536184 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/17/2013US8536163 Therapeutic compositions
09/17/2013US8536149 TRPM-2 antisense therapy
09/17/2013US8536132 Lymphatic zip codes in tumors and pre-malignant lesions
09/17/2013US8535940 Cell growth
09/17/2013US8535899 Assay for identifying a modulator of HIF hydroxylase
09/17/2013US8535690 Tumor specific animal proteins
09/17/2013US8535667 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
09/17/2013US8535655 Biodegradable polymer—bioactive moiety conjugates
09/17/2013CA2775616C Salts of benzimidazole compound and application thereof
09/17/2013CA2740471C Morpholinopurine derivatives
09/17/2013CA2732101C Aurora kinase modulators and methods of use
09/17/2013CA2722418C Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
09/17/2013CA2694136C Pi3 kinase modulators and methods of use
09/17/2013CA2686382C Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors
09/17/2013CA2669503C Compounds and methods for thiol-containing compound efflux and cancer treatment
09/17/2013CA2606081C Combination of the application of antibodies for immunostimulation together with glucocorticoids
09/17/2013CA2604562C Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
09/17/2013CA2562711C Cab molecules
09/17/2013CA2562685C Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
09/17/2013CA2546794C Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
09/17/2013CA2534748C Relaxin superfamily peptide analogues
09/17/2013CA2533789C Epha2 t-cell epitope agonists and uses therefor
09/17/2013CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine
09/17/2013CA2348382C Chimeric parvovirus vectors and methods of making and administering the same
09/17/2013CA2347067C Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
09/17/2013CA2285701C .beta.-catenin, tcf-4, and apc interact to prevent cancer
09/12/2013WO2013134774A1 Modulation of breast cancer growth by modulation of xbp1 activity
09/12/2013WO2013134562A1 Triazolone compounds and uses thereof
09/12/2013WO2013134558A1 Cancer treatment targeting non-coding rna overexpression
09/12/2013WO2013134546A1 Methods and materials for treating cancer
09/12/2013WO2013134398A1 Procaspase combination therapy for glioblastoma
09/12/2013WO2013134349A1 Delivery systems for enhancing drug efficacy
09/12/2013WO2013134288A1 Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
09/12/2013WO2013134252A1 2-amino, 6 - phenyl substituted pyrido [2, 3 - d] pyrimidine derivatives useful as raf kinase inhibitors
09/12/2013WO2013134243A1 2-amino, 6-phenyl substituted pyrido [2, 3 - d] pyrimidine derivatives useful as raf kinase inhibitors
09/12/2013WO2013134230A1 Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer
09/12/2013WO2013134138A1 Engineered antibody-interferon mutant fusion molecules
09/12/2013WO2013134116A1 Hsp90 inhibitor for the treatment of cancer and inflammatory diseases
09/12/2013WO2013134079A1 Oxazolidinone compounds and derivatives thereof
09/12/2013WO2013133556A1 Novel triazolo pyridazine derivative and use therefor
09/12/2013WO2013133450A1 Pharmaceutical composition for treating cancer
09/12/2013WO2013133405A1 Pharmaceutical composition containing peptide
09/12/2013WO2013133393A1 Single-stranded nucleic acid molecule for inhibiting vegf gene expression
09/12/2013WO2013133367A1 Novel triazine derivative
09/12/2013WO2013133351A1 Novel fgfr3 fusion product
09/12/2013WO2013133325A1 Tricyclic compound
09/12/2013WO2013133253A1 Anticancer agent
09/12/2013WO2013132376A1 Macrocyclic derivatives for the treatment of proliferative diseases
09/12/2013WO2013132267A1 Treatment of cancer
09/12/2013WO2013132253A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
09/12/2013WO2013132044A1 Combination therapy of antibodies against human csf-1r and uses thereof
09/12/2013WO2013131931A1 Aminomethylene pyrazolones with therapeutic activity
09/12/2013WO2013131927A1 Combining dna-damaging agents and modulators of actin polymerization for the treatment of cancer
09/12/2013WO2013131465A1 Polymorphs of n-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfinyl)ethylamino)methyl)-2-furanyl)-quinazoline-4-aminexylene sulfonate and preparation method and uses thereof
09/12/2013WO2013131424A1 4-quinazoline amine derivative and application thereof
09/12/2013WO2013131409A1 Phenyl-oxazolyl derivatives, preparation method thereof, and related application of the phenyl-oxazolyl derivatives as an impdh inhibitor
09/12/2013WO2013131143A1 Micrornas and uses thereof
09/12/2013WO2013103301A3 Method for preparing cell targeting conjugates, and the complexes obtained
09/12/2013WO2013058838A3 Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer
09/12/2013WO2013032960A3 Vitamin d receptor - coregulator inhibitors
09/12/2013WO2007024945A8 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
09/12/2013US20130239239 Lmcd1 cancer markers and methods for their use
09/12/2013US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain
09/12/2013US20130237721 Therapeutic compounds and methods of use
09/12/2013US20130237696 Vascular therapeutics
09/12/2013US20130237588 Vascular therapeutics
09/12/2013US20130237572 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
09/12/2013US20130237511 Copper Ion Delivery Platform for Pharmaceutical Agents
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 2211